ELI LILLY & CO (LLY) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:LLY • US5324571083

1107.12 USD
+103.66 (+10.33%)
At close: Feb 4, 2026
1104.85 USD
-2.27 (-0.21%)
Pre-Market: 2/5/2026, 6:46:40 AM
Fundamental Rating

6

Taking everything into account, LLY scores 6 out of 10 in our fundamental rating. LLY was compared to 191 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY has a decent growth rate and is not valued too expensively. Finally LLY also has an excellent dividend rating. With these ratings, LLY could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LLY was profitable.
  • LLY had a positive operating cash flow in the past year.
  • Of the past 5 years LLY 4 years were profitable.
  • LLY had a positive operating cash flow in 4 of the past 5 years.
LLY Yearly Net Income VS EBIT VS OCF VS FCFLLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • LLY's Return On Assets of 16.02% is amongst the best of the industry. LLY outperforms 95.81% of its industry peers.
  • The Return On Equity of LLY (77.38%) is better than 99.48% of its industry peers.
  • With an excellent Return On Invested Capital value of 28.84%, LLY belongs to the best of the industry, outperforming 97.91% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for LLY is significantly above the industry average of 12.83%.
  • The last Return On Invested Capital (28.84%) for LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.84%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
LLY Yearly ROA, ROE, ROICLLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • LLY's Profit Margin of 30.99% is amongst the best of the industry. LLY outperforms 94.76% of its industry peers.
  • In the last couple of years the Profit Margin of LLY has declined.
  • The Operating Margin of LLY (44.41%) is better than 98.43% of its industry peers.
  • LLY's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 83.03%, LLY belongs to the top of the industry, outperforming 86.91% of the companies in the same industry.
  • LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
LLY Yearly Profit, Operating, Gross MarginsLLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for LLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LLY Yearly Shares OutstandingLLY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY Yearly Total Debt VS Total AssetsLLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 8.66 indicates that LLY is not in any danger for bankruptcy at the moment.
  • LLY has a Altman-Z score of 8.66. This is amongst the best in the industry. LLY outperforms 82.20% of its industry peers.
  • LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 6.60, LLY belongs to the best of the industry, outperforming 81.15% of the companies in the same industry.
  • LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • LLY has a worse Debt to Equity ratio (1.72) than 76.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.66
ROIC/WACC3.06
WACC9.43%
LLY Yearly LT Debt VS Equity VS FCFLLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that LLY should not have too much problems paying its short term obligations.
  • LLY has a Current ratio of 1.55. This is in the lower half of the industry: LLY underperforms 71.20% of its industry peers.
  • A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
  • LLY has a Quick ratio of 1.24. This is in the lower half of the industry: LLY underperforms 71.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY Yearly Current Assets VS Current LiabilitesLLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

  • LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.23%, which is quite impressive.
  • Measured over the past years, LLY shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.01% on average per year.
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42.56%

3.2 Future

  • Based on estimates for the next years, LLY will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.21% on average per year.
  • Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 13.06% on average per year.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LLY Yearly Revenue VS EstimatesLLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY Yearly EPS VS EstimatesLLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

5

4. Valuation

4.1 Price/Earnings Ratio

  • LLY is valuated quite expensively with a Price/Earnings ratio of 45.73.
  • 76.44% of the companies in the same industry are more expensive than LLY, based on the Price/Earnings ratio.
  • LLY is valuated expensively when we compare the Price/Earnings ratio to 28.25, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 32.98 indicates a quite expensive valuation of LLY.
  • 72.77% of the companies in the same industry are more expensive than LLY, based on the Price/Forward Earnings ratio.
  • LLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 45.73
Fwd PE 32.98
LLY Price Earnings VS Forward Price EarningsLLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LLY is valued a bit cheaper than the industry average as 79.06% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LLY indicates a somewhat cheap valuation: LLY is cheaper than 74.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 162.61
EV/EBITDA 38.15
LLY Per share dataLLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LLY has an outstanding profitability rating, which may justify a higher PE ratio.
  • LLY's earnings are expected to grow with 23.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)1.83
EPS Next 2Y31.04%
EPS Next 3Y23.44%

7

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.63%, LLY is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.62, LLY pays a better dividend. On top of this LLY pays more dividend than 89.01% of the companies listed in the same industry.
  • With a Dividend Yield of 0.63, LLY pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

  • The dividend of LLY is nicely growing with an annual growth rate of 15.59%!
  • LLY has been paying a dividend for at least 10 years, so it has a reliable track record.
  • LLY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.59%
Div Incr Years10
Div Non Decr Years34
LLY Yearly Dividends per shareLLY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
  • LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
LLY Yearly Income VS Free CF VS DividendLLY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B
LLY Dividend Payout.LLY Dividend Payout, showing the Payout Ratio.LLY Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

NYSE:LLY (2/4/2026, 8:04:00 PM)

Premarket: 1104.85 -2.27 (-0.21%)

1107.12

+103.66 (+10.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner Change-2.24%
Ins Owners0.16%
Ins Owner Change-4.04%
Market Cap1.05T
Revenue(TTM)N/A
Net Income(TTM)18.41B
Analysts81.08
Price Target1164.09 (5.15%)
Short Float %0.82%
Short Ratio2.5
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Yearly Dividend4.93
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years10
Div Non Decr Years34
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)1.91%
PT rev (3m)21.91%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)1.17%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)6.01%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE 45.73
Fwd PE 32.98
P/S 17.61
P/FCF 162.61
P/OCF 65.16
P/B 43.99
P/tB 91.42
EV/EBITDA 38.15
EPS(TTM)24.21
EY2.19%
EPS(NY)33.56
Fwd EY3.03%
FCF(TTM)6.81
FCFY0.61%
OCF(TTM)16.99
OCFY1.53%
SpS62.85
BVpS25.17
TBVpS12.11
PEG (NY)1.18
PEG (5Y)1.83
Graham Number117.09
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.84%
ROICexc 33.25%
ROICexgc 41.06%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.66
F-Score7
WACC9.43%
ROIC/WACC3.06
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42.56%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.81%
EBIT Next 3Y47.2%
EBIT Next 5Y33.2%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%

ELI LILLY & CO / LLY FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 7 / 10 to LLY.


What is the valuation status of ELI LILLY & CO (LLY) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELI LILLY & CO (LLY). This can be considered as Fairly Valued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY) is 45.73 and the Price/Book (PB) ratio is 43.99.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY) is expected to grow by 38.64% in the next year.